Skip to main content
Clinical Trials/ISRCTN51761666
ISRCTN51761666
Recruiting
Not Applicable

Effect of a dietary supplement containing L. plantarum TENSIA® DSM21380 on subjects with high-normal blood pressure up to grade-1 hypertension: a randomised blinded placebo-controlled parallel designed two-armed study

BioCC LLC0 sites200 target enrollmentJune 11, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prehypertension
Sponsor
BioCC LLC
Enrollment
200
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 11, 2018
End Date
December 30, 2020
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
BioCC LLC

Eligibility Criteria

Inclusion Criteria

  • 1\. Written informed consent
  • 2\. Age over 30 years
  • 3\. Willingness to maintain a stable diet and physical activity level
  • 4\. Normal or not clinically relevant deviations in safety laboratory values
  • 5\. High normal or grade 1 systolic/diastolic blood pressure (\=159/99 mm Hg) with up to medium added risks in coronary\-heart diseases
  • 6\. No use of any concomitant treatment (including blood pressure lowering drugs e.g. ACE\-inhibitors, blockers of beta adrenergic receptors, calcium channel blockers and diuretics) and lipid lowering drugs (e.g. statins, bile acid sequestrates, cholesterol absorption inhibitors, nicotinic acid)

Exclusion Criteria

  • 1\. Pregnancy and breastfeeding
  • 2\. (Food) allergy
  • 3\. Intolerance to the investigational product / its ingredients
  • 4\. Diabetes
  • 5\. Eating disorder
  • 6\. Active weight loss \> 5 kg in prior 3 months
  • 7\. Extensive exercise (daily trainings of professional athletes)
  • 8\. Drug or alcohol abuse
  • 9\. Participation in other studies within the last 30 days / during the study
  • 10\. Any history of gastrointestinal diseases

Outcomes

Primary Outcomes

Not specified

Similar Trials